{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:40:28Z","timestamp":1794559228768,"version":"4.9.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41577-020-0337-y","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T08:03:49Z","timestamp":1589184229000},"page":"335-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":432,"title":["BCG-induced trained immunity: can it offer protection against COVID-19?"],"prefix":"10.1038","volume":"20","author":[{"given":"Luke A. J.","family":"O\u2019Neill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-6052","authenticated-orcid":false,"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"337_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"337_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/adc.2009.157537","volume":"95","author":"F Shann","year":"2010","unstructured":"Shann, F. The non-specific effects of vaccines. Arch. Dis. Child 95, 662\u2013667 (2010).","journal-title":"Arch. Dis. Child"},{"key":"337_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby, P. et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J. Infect. Dis. 204, 245\u2013252 (2011).","journal-title":"J. Infect. Dis."},{"key":"337_CR4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","volume":"23","author":"LG Stensballe","year":"2005","unstructured":"Stensballe, L. G. et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. Vaccine 23, 1251\u20131257 (2005).","journal-title":"Vaccine"},{"key":"337_CR5","first-page":"185","volume":"43","author":"Wardhana","year":"2011","unstructured":"Wardhana, et al. The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly. Acta Med. Indones. 43, 185\u2013190 (2011).","journal-title":"Acta Med. Indones."},{"key":"337_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3143\/geriatrics.42.34","volume":"42","author":"T Ohrui","year":"2005","unstructured":"Ohrui, T. et al. Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations [Japanese]. Nihon Ronen Igakkai Zasshi 42, 34\u201336 (2005).","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"337_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes, E. et al. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination. N. Engl. J. Med. 379, 138\u2013149 (2018).","journal-title":"N. Engl. J. Med."},{"key":"337_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/infdis\/136.2.171","volume":"136","author":"JC Spencer","year":"1977","unstructured":"Spencer, J. C., Ganguly, R. & Waldman, R. H. Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guerin. J. Infect. Dis. 136, 171\u2013175 (1977).","journal-title":"J. Infect. Dis."},{"key":"337_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3181\/00379727-152-39327","volume":"152","author":"SE Starr","year":"1976","unstructured":"Starr, S. E. et al. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection. Proc. Soc. Exp. Biol. Med. 152, 57\u201360 (1976).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"337_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0166-3542(85)90025-7","volume":"5","author":"S Ikeda","year":"1985","unstructured":"Ikeda, S., Negishi, T. & Nishimura, C. Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs. Antivir. Res. 5, 207\u2013215 (1985).","journal-title":"Antivir. Res."},{"key":"337_CR11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"S Moorlag","year":"2019","unstructured":"Moorlag, S. et al. Non-specific effects of BCG vaccine on viral infections. Clin. Microbiol. Infect. 25, 1473\u20131478 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"337_CR12","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109, 17537\u201317542 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"337_CR13","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"337_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89\u2013100 (2018).","journal-title":"Cell Host Microbe"},{"key":"337_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/all.14345","author":"M Gursel","year":"2020","unstructured":"Gursel, M. & Gursel, I. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? Allergy https:\/\/doi.org\/10.1111\/all.14345 (2020).","journal-title":"Allergy"},{"key":"337_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0337-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:59:43Z","timestamp":1684605583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-0337-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["337"],"URL":"https:\/\/doi.org\/10.1038\/s41577-020-0337-y","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"11 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}